- Company Directors - S
- Sanders Charles A
Insider Trading History of Sanders Charles A
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Sanders Charles A since 2005.
The trader's CIK number is 1022936.
At the time of the last reporting, Sanders Charles A was the Director of Biocryst Pharmaceuticals Inc. (stock ticker symbol BCRX).
Also see all insider trading activities at Biocryst Pharmaceuticals Inc.
Note that in the past
SANDERS CHARLES A also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Genentech Inc (DNA) by Sanders Charles A
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2008 | DNA | 0 | $0 | 15,000 | $1,065,915 | 15,000 | $279,000 |
Yearly summary of insider trading at Icagen Inc (ICGN) by Sanders Charles A
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2011 | ICGN | 0 | $0 | 0 | $0 | 11,500 | $38,329 |
| 2009 | ICGN | 0 | $0 | 0 | $0 | 2,396 | $1,198 |
Yearly summary of insider trading at Vertex Pharmaceuticals Inc / Ma (VRTX) by Sanders Charles A
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2009 | VRTX | 0 | $0 | 10,000 | $296,432 | 10,000 | $100,498 |
| 2008 | VRTX | 0 | $0 | 10,000 | $271,838 | 10,000 | $141,998 |
| 2007 | VRTX | 0 | $0 | 10,000 | $305,300 | 10,000 | $197,800 |
| 2006 | VRTX | 0 | $0 | 20,000 | $883,510 | 20,000 | $264,600 |
Yearly summary of insider trading at Biopure Corp (BPUR) by Sanders Charles A
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2005 | BPUR | 10,000 | $14,240 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Albireo Pharma, Inc. (BIOD) by Sanders Charles A
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2011 | BIOD | 10,000 | $11,600 | 0 | $0 | 3,937 | $0 |
| 2010 | BIOD | 5,000 | $27,950 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Biocryst Pharmaceuticals Inc (BCRX) by Sanders Charles A
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2012 | BCRX | 2,000 | $10,430 | 0 | $0 | 0 | $0 |
| 2010 | BCRX | 5,000 | $33,300 | 0 | $0 | 0 | $0 |
Insider trading activities at 6 companies by Sanders Charles A:
1. Genentech Inc (DNA)
2. Icagen Inc (ICGN)
3. Vertex Pharmaceuticals Inc / Ma (VRTX)
4. Biopure Corp (BPUR)
5. Albireo Pharma, Inc. (BIOD)
6. Biocryst Pharmaceuticals Inc (BCRX)
Table 1. Insider trading of Genentech Inc (DNA) by Sanders Charles A
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2008-02-06 | DNA | Option Ex | 15,000 | 18.60 | 279,000 |
| 2008-02-06 | DNA | Sale | 15,000 | 71.06 | 1,065,915 |
Table 2. Insider trading of Icagen Inc (ICGN) by Sanders Charles A
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2011-09-01 | ICGN | Option Ex | 11,500 | 3.33 | 38,329 |
| 2009-12-17 | ICGN | Option Ex | 2,396 | .50 | 1,198 |
Table 3. Insider trading of Vertex Pharmaceuticals Inc / Ma (VRTX) by Sanders Charles A
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2009-05-18 | VRTX | Sale | 3,333 | 28.44 | 94,790 |
| 2009-05-18 | VRTX | Option Ex | 3,333 | 10.05 | 33,496 |
| 2009-05-11 | VRTX | Sale | 3,333 | 30.41 | 101,356 |
| 2009-05-11 | VRTX | Option Ex | 3,333 | 10.05 | 33,496 |
| 2009-05-04 | VRTX | Option Ex | 3,334 | 10.05 | 33,506 |
| 2009-05-04 | VRTX | Sale | 3,334 | 30.08 | 100,286 |
| 2008-05-27 | VRTX | Sale | 3,333 | 26.75 | 89,147 |
| 2008-05-27 | VRTX | Option Ex | 3,333 | 14.20 | 47,328 |
| 2008-05-20 | VRTX | Option Ex | 3,333 | 14.20 | 47,328 |
| 2008-05-20 | VRTX | Sale | 3,333 | 27.59 | 91,960 |
| 2008-05-13 | VRTX | Option Ex | 3,334 | 14.20 | 47,342 |
| 2008-05-13 | VRTX | Sale | 3,334 | 27.21 | 90,731 |
| 2007-05-07 | VRTX | Option Ex | 10,000 | 19.78 | 197,800 |
| 2007-05-07 | VRTX | Sale | 10,000 | 30.53 | 305,300 |
| 2006-12-07 | VRTX | Option Ex | 3,000 | 13.23 | 39,690 |
| 2006-12-08 | VRTX | Option Ex | 2,000 | 13.23 | 26,460 |
| 2006-12-07 | VRTX | Sale | 3,000 | 43.97 | 131,910 |
| 2006-12-08 | VRTX | Sale | 2,000 | 42.95 | 85,900 |
| 2006-12-06 | VRTX | Sale | 3,000 | 44.71 | 134,130 |
| 2006-12-06 | VRTX | Option Ex | 3,000 | 13.23 | 39,690 |
| 2006-12-05 | VRTX | Option Ex | 3,000 | 13.23 | 39,690 |
| 2006-12-05 | VRTX | Sale | 3,000 | 44.51 | 133,530 |
| 2006-12-04 | VRTX | Option Ex | 3,000 | 13.23 | 39,690 |
| 2006-12-04 | VRTX | Sale | 3,000 | 44.28 | 132,840 |
| 2006-12-01 | VRTX | Option Ex | 3,000 | 13.23 | 39,690 |
| 2006-12-01 | VRTX | Sale | 3,000 | 43.86 | 131,580 |
| 2006-11-30 | VRTX | Sale | 3,000 | 44.54 | 133,620 |
| 2006-11-30 | VRTX | Option Ex | 3,000 | 13.23 | 39,690 |
Table 4. Insider trading of Biopure Corp (BPUR) by Sanders Charles A
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2005-08-30 | BPUR | Buy | 10,000 | 1.42 | 14,240 |
Table 5. Insider trading of Albireo Pharma, Inc. (BIOD) by Sanders Charles A
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2011-09-30 | BIOD | Option Ex | 3,937 | .00 | 0 |
| 2011-08-10 | BIOD | Buy | 10,000 | 1.16 | 11,600 |
| 2010-05-11 | BIOD | Buy | 5,000 | 5.59 | 27,950 |
Table 6. Insider trading of Biocryst Pharmaceuticals Inc (BCRX) by Sanders Charles A
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2012-03-13 | BCRX | Buy | 2,000 | 5.21 | 10,430 |
| 2010-02-08 | BCRX | Buy | 5,000 | 6.66 | 33,300 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Sanders Charles A
(Director of Biocryst Pharmaceuticals Inc at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.